This research compound was initial described by Hoffman-La Roche in 2009. It’s one of various benzodiazepines from the imidazobenzodiazepine subgroup considered to supply nootropic Added benefits. This drug was invented by Schlesinger Walter and marketed inside the early 80s. It was bought as being “less harmful” than chlordiazepoxide (Librium) and https://stevea411qhn7.blogadvize.com/profile